肠系膜脂膜炎合并卡氏肺孢子菌肺炎1例报告
Reports of a Case of Mesenteric Panniculitis Complicated with Pneumocystis Carinii Pneumonia
摘要: 目的：探讨肠系膜脂膜炎合并卡氏肺孢子菌肺炎的临床表现、诊断方法及治疗策略，加强对肠系膜脂膜炎合并卡氏肺孢子菌肺炎的理解。方法：介绍1例肠系膜脂膜炎合并卡氏肺孢子菌肺炎的临床资料，并进行相关文献复习。结果：该患者在服用激素治疗肠系膜脂膜炎减量过程中出现胸闷、憋气、发热，胸部CT出现双肺多发磨玻璃影，确诊肠系膜脂膜炎合并卡氏肺孢子菌肺炎，应用复方新诺明及卡波芬净及时治疗后好转出院。结论：肠系膜脂膜炎合并卡氏肺孢子菌肺炎如能早期确诊，治疗效果较好。
Abstract: Objective: To investigate the clinical features, diagnosis and treatment strategies of patients with mesenteric panniculitis (MP) complicated with pneumocystis carinii pneumonia (PCP), and to strengthen the understanding of mesenteric panniculitis complicated with Pneumocystis carinii pneumonia. Methods: Introduce the clinical data of 1 case of mesenteric panniculitis complicated with pneumocystis carinii pneumonia, and review the relevant literature. Results: The patient diagnosed with mesenteric panniculitis combined with Pneumocystis carinii pneumonia is treated promptly, and is discharged from the hospital. The outpatient return visit did not have obvious respiratory symptoms. Conclusion: If patients with mesenteric panniculitis complicated with Pneumocystis carinii pneumonia can be diagnosed early, the treatment effect is better.
文章引用：刘珍慧, 王志强, 栾琳慧, 万甜甜, 于文成. 肠系膜脂膜炎合并卡氏肺孢子菌肺炎1例报告[J]. 临床医学进展, 2021, 11(4): 1832-1837. https://doi.org/10.12677/ACM.2021.114263

参考文献

[1] Kovacs, J.A., et al. (1984) Pneumocystis Carinii Pneumonia: A Comparison between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies. Annals of Internal Medicine, 100, 663-671. [Google Scholar] [CrossRef] [PubMed]
[2] Beck, J.M., et al. (1991) Inflammatory Responses to Pneumocystis Carinii in Mice Selectively Depleted of Helper T Lymphocytes. American Journal of Respiratory Cell and Molecular Biology, 5, 186-197. [Google Scholar] [CrossRef] [PubMed]
[3] Limper, A.H. and Martin, W.J. (1990) Pneumocystis Carinii: Inhibition of Lung Cell Growth Mediated by Parasite Attachment. Journal of Clinical Investigation, 85, 391-396. [Google Scholar] [CrossRef] 
[4] Chapman, J.R., et al. (2013) Post-Transplant Pneumocystis jirovecii Pneumonia—A Re-Emerged Public Health Problem? Kidney International, 84, 240-243. [Google Scholar] [CrossRef] [PubMed]
[5] Morris, A. and Norris, K.A. (2012) Colonization by Pneumocystis jirovecii and Its Role in Disease. Clinical Microbiology Reviews, 25, 297-317. [Google Scholar] [CrossRef] 
[6] Chen, M., et al. (2015) Pneumocystis Pneumonia in Patients with Autoimmune Diseases: A Retrospective Study Focused on Clinical Characteristics and Prognostic Factors Related to Death. PLoS ONE, 10, e0139144. [Google Scholar] [CrossRef] [PubMed]
[7] Saltzman, R.W., et al. (2012) Clinical Conditions Associated with PCP in Children. Pediatric Pulmonology, 47, 510-516. [Google Scholar] [CrossRef] [PubMed]
[8] Bienvenu, A.L., et al. (2016) Pneumocystis Pneumonia Suspected Cases in 604 Non-HIV and HIV Patients. International Journal of Infectious Diseases, 46, 11-17. [Google Scholar] [CrossRef] [PubMed]
[9] Desales, A.L., et al. (2012) Pneumocystosis in a Patient with Crohn’s Disease Treated with Combination Therapy with Adalimumab. Journal of Crohn’s and Colitis, 6, 483-487. [Google Scholar] [CrossRef] [PubMed]
[10] Baulier, G., et al. (2018) Guidelines for Prophylaxis of Pneumocystis Pneumonia Cannot Rely Solely on CD4-Cell Count in Autoimmune and Inflammatory Diseases. Clinical and Experimental Rheumatology, 36, 490-493.
[11] Stamp, L.K. and Hurst, M. (2010) Is There a Role for Consensus Guidelines for P. jiroveci Pneumonia Prophylaxis in Immunosuppressed Patients with Rheumatic Diseases? The Journal of Rheumatology, 37, 686-688. [Google Scholar] [CrossRef] [PubMed]
[12] Park, J.W., et al. (2018) Prophylactic Effect of Trimethoprim-Sulfamethoxazole for Pneumocystis Pneumonia in Patients with Rheumatic Diseases Exposed to Prolonged High-Dose Glucocorticoids. Annals of the Rheumatic Diseases, 77, 644-649. [Google Scholar] [CrossRef] [PubMed]
[13] Salzer, H.J.F., et al. (2018) Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia. Respiration, 96, 52-65. [Google Scholar] [CrossRef] [PubMed]
[14] Akram, S., et al. (2007) Sclerosing Mesenteritis: Clinical Features, Treatment, and Outcome in Ninety-Two Patients. Clinical Gastroenterology and Hepatology, 5, 589-596. [Google Scholar] [CrossRef] [PubMed]
[15] Sharma, P., et al. (2017) Sclerosing Mesenteritis: A Systematic Review of 192 Cases. Clinical Journal of Gastroenterology, 10, 103-111. [Google Scholar] [CrossRef] [PubMed]
[16] Mizuno, S., et al. (2017) Increased Levels of Prostaglandin E-Major Urinary Metabolite (PGE-MUM) in Active Mesenteric Panniculitis Patients: A Case Report. Medicine (Baltimore), 96, e9237. [Google Scholar] [CrossRef] 
[17] Hussein, M.R. and Abdelwahed, S.R. (2015) Mesenteric Panniculitis: An Update. Expert Review of Gastroenterology & Hepatology, 9, 67-78. [Google Scholar] [CrossRef] [PubMed]
[18] Coulier, B., et al. (2017) Synchronous Association of Typical and Transient Mesenteric Panniculitis with Acute Gastrointestinal Attack of Adult-Onset Henoch-Schönlein Purpura. Diagnostic and Interventional Imaging, 98, 571-573. [Google Scholar] [CrossRef] [PubMed]
[19] Schmidt, J.J., et al. (2018) Clinical Course, Treatment and Outcome of Pneumocystis Pneumonia in Immunocompromised Adults: A Retrospective Analysis over 17 Years. Critical Care, 22, 307. [Google Scholar] [CrossRef] [PubMed]
[20] Roux, A., et al. (2014) Pneumocystis jirovecii Pneumonia in Patients with or without AIDS, France. Emerging Infectious Diseases, 20, 1490-1497. [Google Scholar] [CrossRef] [PubMed]
[21] Fillatre, P., et al. (2014) Incidence of Pneumocystis jiroveci Pneumonia among Groups at Risk in HIV-Negative Patients. The American Journal of Medicine, 127, 1242.e11-7. [Google Scholar] [CrossRef] [PubMed]
[22] Messiaen, P.E., et al. (2017) The Role of CD4 Cell Count as Discriminatory Measure to Guide Chemoprophylaxis against Pneumocystis jirovecii Pneumonia in Human Immunodeficiency Virus-Negative Immunocompromised Patients: A Systematic Review. Transplant Infectious Disease, 19, e12651. [Google Scholar] [CrossRef] [PubMed]
[23] Ward, M.M. and Donald, F. (1999) Pneumocystis Carinii Pneumonia in Patients with Connective Tissue Diseases: The Role of Hospital Experience in Diagnosis and Mortality. Arthritis & Rheumatology, 42, 780-789. [Google Scholar] [CrossRef] 
[24] Falagas, M.E., et al. (2007) Infection-Related Morbidity and Mortality in Patients with Connective Tissue Diseases: A Systematic Review. Clinical Rheumatology, 26, 663-670. [Google Scholar] [CrossRef] [PubMed]
[25] Monnet, X., et al. (2008) Critical Care Management and Outcome of Severe Pneumocystis Pneumonia in Patients with and without HIV Infection. Critical Care, 12, R28. [Google Scholar] [CrossRef] [PubMed]
[26] Grubbs, J.A. and Baddley, J.W. (2014) Pneumocystis jirovecii Pneumonia in Patients Receiving Tumor-Necrosis-Fac- tor-Inhibitor Therapy: Implications for Chemoprophylaxis. Current Rheumatology Reports, 16, 445. [Google Scholar] [CrossRef] [PubMed]
[27] Martin-Garrido, I., et al. (2013) Pneumocystis Pneumonia in Patients Treated with Rituximab. Chest, 144, 258-265. [Google Scholar] [CrossRef] [PubMed]
[28] Okafor, P.N., Nunes, D.P. and Farraye, F.A. (2013) Pneumocystis jiroveci Pneumonia in Inflammatory Bowel Disease: When Should Prophylaxis Be Considered? Inflammatory Bowel Diseases, 19, 1764-1771. [Google Scholar] [CrossRef] 
[29] Yu, Q., et al. (2017) Outcomes and Prognostic Factors of Non-HIV Patients with Pneumocystis jirovecii Pneumonia and Pulmonary CMV Co-Infection: A Retrospective Cohort Study. BMC Infectious Diseases, 17, 392. [Google Scholar] [CrossRef] [PubMed]
[30] Calero-Bernal, M.L., et al. (2016) Intermittent Courses of Corticosteroids Also Present a Risk for Pneumocystis Pneumonia in Non-HIV Patients. Canadian Respiratory Journal, 2016, Article ID: 2464791. [Google Scholar] [CrossRef] [PubMed]
[31] Wasserman, S., et al. (2016) Burden of Pneumocystis Pneumonia in HIV-Infected Adults in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. BMC Infectious Diseases, 16, 482. [Google Scholar] [CrossRef] [PubMed]
[32] Bakeera-Kitaka, S., et al. (2004) Pneumocystis Carinii in Children with Severe Pneumonia at Mulago Hospital, Uganda. Annals of Tropical Paediatrics, 24, 227-235. [Google Scholar] [CrossRef] [PubMed]
[33] Stern, A., et al. (2014) Prophylaxis for Pneumocystis Pneumonia (PCP) in Non-HIV Immunocompromised Patients. Cochrane Database of Systematic Reviews, No. 10, CD005590. [Google Scholar] [CrossRef] 
[34] Tasaka, S., et al. (2007) Serum Indicators for the Diagnosis of Pneumocystis Pneumonia. Chest, 131, 1173-1180. [Google Scholar] [CrossRef] [PubMed]
[35] Desmet, S., et al. (2009) Serum (1-3)-beta-D-glucan as a Tool for Diagnosis of Pneumocystis jirovecii Pneumonia in Patients with Human Immunodeficiency Virus Infection or Hematological Malignancy. Journal of Clinical Microbiology, 47, 3871-3874. [Google Scholar] [CrossRef] 
[36] Mansharamani, N.G., et al. (2000) Management and Outcome Patterns for Adult Pneumocystis Carinii Pneumonia, 1985 to 1995: Comparison of HIV-Associated Cases to Other Immunocompromised States. Chest, 118, 704-711. [Google Scholar] [CrossRef] [PubMed]

为你推荐